These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 1603047)
1. [A comparative analysis of interval breast cancer with breast cancer detected by mass screening or in outpatient clinics]. Komaki K; Morimoto T; Oshimo K; Mori T; Sasa M; Konishi Y; Monden Y Nihon Geka Gakkai Zasshi; 1992 Apr; 93(4):413-8. PubMed ID: 1603047 [TBL] [Abstract][Full Text] [Related]
2. The characteristics of interval breast cancer in mass screening. Morimoto T; Komaki K; Oshimo K; Miki H; Sasa M; Mori T; Tsuzuki H; Kamamura Y; Monden Y Tokushima J Exp Med; 1992 Dec; 39(3-4):109-16. PubMed ID: 1295127 [TBL] [Abstract][Full Text] [Related]
3. Comparisons of interval breast cancers with other breast cancers detected through mass screening and in outpatient clinics in Japan. Yoshida K; Abe R; Itoh S; Taguchi T; Ohta J; Morimoto T; Ishida T; Tashiro H; Ogita M; Kido C Jpn J Clin Oncol; 1990 Dec; 20(4):374-9. PubMed ID: 2283721 [TBL] [Abstract][Full Text] [Related]
4. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999. Zackrisson S; Janzon L; Manjer J; Andersson I J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086 [TBL] [Abstract][Full Text] [Related]
5. [Breast cancer detected by mass screening using physical examination alone]. Morimoto T; Komaki K; Monden Y Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):944-51. PubMed ID: 3389838 [TBL] [Abstract][Full Text] [Related]
6. [Mass screening for breast cancer in Gunma prefecture--the results for 8 years and future problems]. Ishida T; Yokoe T; Ogawa T; Kurosumi M; Kurebayashi J; Yoshida M; Yamada I; Iino Y; Izuo M Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2400-10. PubMed ID: 2614178 [TBL] [Abstract][Full Text] [Related]
7. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. Lynge E APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674 [TBL] [Abstract][Full Text] [Related]
8. [Current problems in mass screening for breast cancer]. Morimoto T; Yamakawa T; Mitsuyama N Gan To Kagaku Ryoho; 1985 Dec; 12(12):2273-83. PubMed ID: 4073925 [TBL] [Abstract][Full Text] [Related]
9. [Mass screening for breast cancer in Japan]. Ota J Gan To Kagaku Ryoho; 1991 Oct; 18(13):2210-6. PubMed ID: 1929440 [TBL] [Abstract][Full Text] [Related]
10. Recurrence-free survival in patients with small breast cancer. An analysis of cancers 10 mm or less detected clinically and by screening. Arnesson LG; Smeds S; Fagerberg G Eur J Surg; 1994 May; 160(5):271-6. PubMed ID: 8075195 [TBL] [Abstract][Full Text] [Related]
11. [Pathological characteristics in screening versus clinically-detected breast cancer]. Paziault M; Terrade FX; Fermeaux V; Pascal B; Darreye G; Dussartre C; Gilquin M; Labrousse F; Tubiana-Mathieu N Bull Cancer; 2006 Jul; 93(7):731-6. PubMed ID: 16873082 [TBL] [Abstract][Full Text] [Related]
12. Management of bilateral breast carcinoma: long-term results. Goksel HA; Yagmurdur MC; Karakayali H; Moray G; Demirhan B; Isiklar I; Bilgin N; Haberal M Int Surg; 2004; 89(3):166-71. PubMed ID: 15521255 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of mass screening for thyroid cancer. Ishida T; Izuo M; Ogawa T; Kurebayashi J; Satoh K Jpn J Clin Oncol; 1988 Dec; 18(4):289-95. PubMed ID: 3204679 [TBL] [Abstract][Full Text] [Related]
14. Update of the Swedish two-county program of mammographic screening for breast cancer. Tabàr L; Fagerberg G; Duffy SW; Day NE; Gad A; Gröntoft O Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926 [TBL] [Abstract][Full Text] [Related]
15. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis. Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112 [TBL] [Abstract][Full Text] [Related]
16. [Significance of mammography study in the detection of 2,511 breast cancers 1977 to 1987]. Leonhardt A Geburtshilfe Frauenheilkd; 1988 Feb; 48(2):72-7. PubMed ID: 3366350 [TBL] [Abstract][Full Text] [Related]
17. [Clinical detection of 2,511 breast cancers 1977-1986. Efficiency of legal early cancer detection studies]. Leonhardt A Geburtshilfe Frauenheilkd; 1988 Feb; 48(2):92-8. PubMed ID: 3366351 [TBL] [Abstract][Full Text] [Related]
18. Triple-negative breast cancer in West Virginia. Abraham J; Flanagan M; Hazard H; Jubelirer S; Tirona MT; Vona-Davis L W V Med J; 2009 Oct; 105 Spec No():54-9. PubMed ID: 19999267 [TBL] [Abstract][Full Text] [Related]
19. Interval breast cancers: prognostic features and survival by subtype and time since screening. Porter GJ; Evans AJ; Burrell HC; Lee AH; Ellis IO; Chakrabarti J J Med Screen; 2006; 13(3):115-22. PubMed ID: 17007651 [TBL] [Abstract][Full Text] [Related]
20. Infiltrating lobular carcinoma of the breast detected by screening. Schroën AM; Wobbes T; van der Sluis RF Br J Surg; 1998 Mar; 85(3):390-2. PubMed ID: 9529500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]